US 6365616
Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
expired A61KA61K31/4164A61K31/4166
Quick answer
US patent 6365616 (Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 44
- CPC classes
- A61K, A61K31/4164, A61K31/4166, A61K31/421, A61K31/426